Shares of OptimizeRx OPRX moved lower in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 400.00% year over year to $0.10, which beat the estimate of $0.07.
Revenue of $13,626,000 higher by 55.14% year over year, which beat the estimate of $12,450,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
OptimizeRx hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Aug 04, 2021
Time: 04:30 PM
ET Webcast URL: https://viavid.webcasts.com/starthere.jsp?ei=1484054&tp_key=7eacf33079
Price Action
Company's 52-week high was at $63.98
Company's 52-week low was at $13.97
Price action over last quarter: Up 10.73%
Company Description
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
